This compound is a pharmaceutical intermediate primarily used in peptide synthesis. It features a complex molecular structure with multiple aromatic rings and ether linkages, characteristic of protected amino acid derivatives.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-[(2,4-Dimethoxyphenyl)(Fmoc-amino)methyl]phenoxyacetic acid
pharmaceutical intermediate
Fmoc-AEEA-AEEA
pharmaceutical intermediate
N-Boc-D-glutamic acid 1-(tert-butyl) ester
pharmaceutical intermediate
N(alpha)-t-butoxycarbonyl-L-asparagine
pharmaceutical intermediate
(5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid
pharmaceutical intermediate
2-cyanoethyl 3-aminocrotonate
pharmaceutical intermediate
4-(Trifluoromethoxy)phenylacetic acid
pharmaceutical intermediate
6-chloro-3-methyluracil
pharmaceutical intermediate
9H-fluoren-9-ylmethyl N-[[4-[2-[bis(4-methylphenyl)methylamino]-2-oxoethoxy]phenyl]-(2,4-dimethoxyphenyl)methyl]carbamate
JDDWRLPTKIOUOF-UHFFFAOYSA-N
CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)NC(=O)COC3=CC=C(C=C3)C(C4=C(C=C(C=C4)OC)OC)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.